Beta-adrenergic blockers include-

Atenolol, Acebutol, Betaxolol,    Bisoprolol,Cartelol,Esmolol,   Labetatol,Metoprolol, Nadolol,Penbutolol, Pinodol, Propranolol,   Solatol, Timolol,

  Refer - Atenolol
 

Depressant action on myocardium may occasionally be fatal. Bradycardia, lassitude, cold
extremities, GI and sleep  disturbances, skin rashes, dry eyes (discontinue therapy).
Significant rise in triglycerides and VLDL. Reduction in HDL and ratio of HDL to LDL.

 

Known hypersensitivity to drug and related derivatives, atrioventricular block of 2nd and 3rd
degree.  Sick sinus syndrome, decompensated heart failure, clinically relevent  sinus
bradycardia. Severe peripheral arterial circulatory disorders. Cardiogenic shock.

Special precautions:
Obstructive pulmonary disease. Heart failure patients should treat their decompensation before and during treatment.  AV conduction disorders, bradycardia, peripheral arterial circulatory disorders, liver cirrhosis, phaeochromocytoma. Withdraw drug gradually when discontinuing.
Pregnancy, lactation,road users.

 

Date of Approval-     1982

Indications:

Hypertension

Dosage:
100mg/day in a single or divided dose, used alone or with a diuretic.

 

Beta-adrenergic blockers include- Atenolol, Acebutol, Betaxolol, Bismoprolol,Cartelol,Esmolol, Labetatol,Metoprolol,
                                                 Nadolol,Penbutolol, Pinodol, Propranolol, Solatol, Timolol,
                                                 Refer - Atenolol
 

Refer- Atenolol- Beta adrenergic blocker

Increased bioavailability

Refer - Atenolol- Beta adrenergic blocker